Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Acumen Pharmaceuticals, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1/A
Revenues  0.00.01.48.6
            Revenue growth   -100.0%-83.3% 
Cost of goods sold  0.00.00.015.5
Gross profit  0.00.01.4-6.9
            Gross margin    100.0%-80.2%
Selling, general and administrative   [+]12.97.31.40.9
Research and development  32.412.38.0 
Other operating expenses   -81.20.6 
EBITDA   [+]-45.261.6  
            EBITDA margin    -591.8%-91.0%
Depreciation and amortization  0.00.0  
EBIT   [+]-45.261.6-8.5-7.8
            EBIT margin    -591.8%-91.0%
Non-recurring items   81.2-0.6 
Interest income  2.40.10.00.0
Other income (expense), net  0.0-81.10.6-0.1
Pre-tax income  -42.9-100.6-7.3-7.9
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -42.9-100.6-7.30.0
            Net margin    -510.1%-0.1%
   
Basic EPS   [+]($1.06)($5.02)($17.48)($17.84)
Diluted EPS   [+]($1.06)($5.02)($17.48)($17.84)
   
Shares outstanding (basic)   [+]40.620.10.40.0
Shares outstanding (diluted)   [+]40.620.10.40.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy